Valeant Pharmaceuticals

Valeant Pharmaceuticals International Inc., formerly Biovail Corporation, is a Canadian specialty pharmaceutical company engaged in the application of drug-delivery technologies to improve the clinical effectiveness of medicines. Its therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease (including Type II diabetes).

Additional Information
Market: TSX
Sector: Pharmaceuticals & Biotech
Latest Price: 239.62  (0.60% Ascending)
52-week High: 346.32
52-week Low: 128.54
Market Cap: 81,756.20M
1 year chart
1 day chart